Unilab (Philippines) Inc:企業の戦略的SWOT分析

◆英語タイトル:Unilab (Philippines) Inc - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2894
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィリピン
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥56,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Unilab (Philippines) Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Unilab (Philippines) Inc (Unilab) is a pharmaceutical and healthcare company that develops, manufactures and distributes prescription, consumer healthcare and personal care products. It offers products across a wide range of therapeutic areas including anti-infectives, cardiovascular, central nervous system, gastrointestinal, oncology, endometabolics, cough-cold, and oral care among others. The company’s brands portfolio include Vidastat, Lifezar, Levox, Combizar, Glumet, Norizec, Asmalin, Rimaped and others. Unilab promotes the products through a network of trained direct sales force and tri-media advertisements. It has affiliates in Sri Lanka, Myanmar, Thailand, Malaysia, China, Hong Kong, Vietnam, Laos and Singapore and operates through manufacturing facilities in South East Asia. Unilab is headquartered in Mandaluyong City, the Philippines.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Unilab (Philippines) Inc – Key Facts
Unilab (Philippines) Inc – Key Employees
Unilab (Philippines) Inc – Major Products and Services
Unilab (Philippines) Inc – History
Unilab (Philippines) Inc – Company Statement
Unilab (Philippines) Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Unilab (Philippines) Inc – Business Description
Unilab (Philippines) Inc – SWOT Analysis
SWOT Analysis – Overview
Unilab (Philippines) Inc – Strengths
Unilab (Philippines) Inc – Weaknesses
Unilab (Philippines) Inc – Opportunities
Unilab (Philippines) Inc – Threats
Unilab (Philippines) Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Unilab (Philippines) Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Unilab (Philippines) Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Unilab (Philippines) Inc, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Unilab (Philippines) Inc, Key Facts
Unilab (Philippines) Inc, Key Employees
Unilab (Philippines) Inc, Major Products and Services
Unilab (Philippines) Inc, History
Unilab (Philippines) Inc, Subsidiaries
Unilab (Philippines) Inc, Key Competitors
Unilab (Philippines) Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Unilab (Philippines) Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Unilab (Philippines) Inc, Recent Deals Summary

List of Figures
Unilab (Philippines) Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Unilab (Philippines) Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Unilab (Philippines) Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MolMed SpA (MLM):企業の財務・戦略的SWOT分析
    Summary MolMed SpA (Molmed) is a biotechnology company which offers research, development, manufacturing and clinical validation of novel anticancer therapies. Its pipeline antitumour products include Zalmoxis (TK), a cell based therapy enabling bone marrow transplants donors for the treatment of hi …
  • TransDigm Group Incorporated:企業の戦略・SWOT・財務情報
    TransDigm Group Incorporated - Strategy, SWOT and Corporate Finance Report Summary TransDigm Group Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Genera Biosystems Ltd (GBI):医療機器:M&Aディール及び事業提携情報
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • Gerdau S.A.:戦略・SWOT・企業財務分析
    Gerdau S.A. - Strategy, SWOT and Corporate Finance Report Summary Gerdau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Medikit Co Ltd (7749):企業の製品パイプライン分析
    Summary Medikit Co Ltd (Medikit) is a medical equipment provider that offers vascular devices. The company offers IV catheter, hemodialysis and intervention products. Its products include supercath Z3V, supercath 5 safety IV catheter, supercath AZ, supercath CLS, i-works, seiha, parent plus, parent …
  • Assertio Therapeutics Inc (ASRT):企業の財務・戦略的SWOT分析
    Assertio Therapeutics Inc (ASRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Univar Inc (UNVR):企業の財務・戦略的SWOT分析
    Univar Inc (UNVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Finning International Inc. (FTT):企業の財務・戦略的SWOT分析
    Finning International Inc. (FTT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • CJ Corp (001040):企業の財務・戦略的SWOT分析
    CJ Corp (001040) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MEDITE Cancer Diagnostics Inc (MDIT):企業の財務・戦略的SWOT分析
    MEDITE Cancer Diagnostics Inc (MDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Zynex Inc (ZYXI):企業の財務・戦略的SWOT分析
    Summary Zynex Inc (Zynex) formerly Zynex Medical Inc operates as a medical technology company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. The company’s products include NexWave, a dual channel, multi-modality interferential curr …
  • Berkeley Energia Ltd:企業の戦略・SWOT・財務分析
    Berkeley Energia Ltd - Strategy, SWOT and Corporate Finance Report Summary Berkeley Energia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Inoviem Scientific SAS-製薬・医療分野:企業M&A・提携分析
    Summary Inoviem Scientific SAS (Inoviem) is a contract research biotechnology company that offers preclinical and clinical services. The company develops solutions in the field of drug target interaction analysis and drug development. Its technologies include physiological intermolecular modulation …
  • Mylan N.V.:戦略・SWOT・企業財務分析
    Mylan N.V. - Strategy, SWOT and Corporate Finance Report Summary Mylan N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Krosaki Harima Corporation:企業の戦略・SWOT・財務情報
    Krosaki Harima Corporation - Strategy, SWOT and Corporate Finance Report Summary Krosaki Harima Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ellex Medical Lasers Limited (ELX):医療機器:M&Aディール及び事業提携情報
    Summary Ellex Medical Lasers Limited (Ellex) is a medical technology company that develops, manufactures, sells and distributes medical equipment for use in ophthalmic procedures. The company also offers a range of third-party medical devices and technologies. Ellex’s product portfolio includes lase …
  • Softchoice Corporation:企業の戦略的SWOT分析
    Softchoice Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Qiagen Aarhus AS:企業の戦略的SWOT分析
    Qiagen Aarhus AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • OraSure Technologies Inc (OSUR):企業の財務・戦略的SWOT分析
    OraSure Technologies Inc (OSUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Drugs for Neglected Diseases initiative:企業のM&A・事業提携・投資動向
    Drugs for Neglected Diseases initiative - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Drugs for Neglected Diseases initiative Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆